Matrix metalloproteinases and atherosclerosis
Piotr Fic(Wojewódzki Szpital Specjalistyczny we Wrocławiu), Andrzej Stepulak, Jacek Kurzepa(Medical University of Lublin), Izabela Zakrocka(Medical University of Lublin)
Cited by 34
Related Papers
Kynurenine pathway in kidney diseases
|Pharmacological Reports|2021|53
Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
|Neurotoxicity Research|2017|36
Effects of systemic administration of kynurenic acid and glycine on renal haemodynamics and excretion in normotensive and spontaneously hypertensive rats
|European Journal of Pharmacology|2014|26
Kynurenic acid selectively reduces heart rate in spontaneously hypertensive rats
|Naunyn-Schmiedeberg s Archives of Pharmacology|2019|18